These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 16142317

  • 21. Estrogen receptor-alpha, bcl-2 and c-myc gene expression in fibroadenomas and adjacent normal breast: association with nodule size, hormonal and reproductive features.
    Cericatto R, Pozzobon A, Morsch DM, Menke CH, Brum IS, Spritzer PM.
    Steroids; 2005 Mar; 70(3):153-60. PubMed ID: 15763593
    [Abstract] [Full Text] [Related]

  • 22. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
    Tsanou E, Ioachim E, Briasoulis E, Charchanti A, Damala K, Karavasilis V, Pavlidis N, Agnantis NJ.
    J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
    [Abstract] [Full Text] [Related]

  • 23. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis.
    Cohen C, Lohmann CM, Cotsonis G, Lawson D, Santoianni R.
    Mod Pathol; 2003 Jun; 16(6):574-83. PubMed ID: 12808063
    [Abstract] [Full Text] [Related]

  • 24. p65 and c-erbB2 genes expression in breast tumors: comparison with some histological typing, grading and clinical staging.
    Balcerczak E, Mirowski M, Jesionek-Kupnicka D, Bartkowiak J, Kubiak R, Wierzbicki R.
    J Exp Clin Cancer Res; 2003 Jun; 22(2):247-53. PubMed ID: 12866575
    [Abstract] [Full Text] [Related]

  • 25. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes.
    Arun B, Kilic G, Yen C, Foster B, Yardley D, Gaynor R, Ashfaq R.
    Cancer; 2003 Dec 15; 98(12):2554-9. PubMed ID: 14669273
    [Abstract] [Full Text] [Related]

  • 26. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells.
    Chen XM, Luan XY, Lei DP, Ma XJ, Liu XX, Liu J, Pan XL.
    ORL J Otorhinolaryngol Relat Spec; 2008 Dec 15; 70(3):168-75. PubMed ID: 18391576
    [Abstract] [Full Text] [Related]

  • 27. Bcl-2 expression in breast cancer: a comparative study at the mRNA and protein level.
    Martínez-Arribas F, Alvarez T, Del Val G, Martín-Garabato E, Núñez-Villar MJ, Lucas R, Sánchez J, Tejerina A, Schneider J.
    Anticancer Res; 2007 Dec 15; 27(1A):219-22. PubMed ID: 17352236
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes.
    Cobleigh MA, Tabesh B, Bitterman P, Baker J, Cronin M, Liu ML, Borchik R, Mosquera JM, Walker MG, Shak S.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8623-31. PubMed ID: 16361546
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Relevance of c-erbB2, PLU-1 and survivin mRNA expression to diagnostic assessment of breast cancer.
    Izawa A, Kobayashi D, Nasu S, Saito K, Moriai R, Asanuma K, Nakamura M, Yagihashi A, Watanabe N.
    Anticancer Res; 2002 Dec 15; 22(5):2965-9. PubMed ID: 12530026
    [Abstract] [Full Text] [Related]

  • 33. A laminin-rich basement membrane matrix influences estrogen receptor beta expression and morphology of MDA-MB-231 breast cancer cells.
    Neubauer H, Ruoff A, Paessler N, Solomayer E, Wallwiener D, Fehm T.
    Oncol Rep; 2009 Feb 15; 21(2):475-81. PubMed ID: 19148525
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer.
    Koda M, Sulkowska M, Kanczuga-Koda L, Tomaszewski J, Kucharczuk W, Lesniewicz T, Cymek S, Sulkowski S.
    Oncol Rep; 2007 Jul 15; 18(1):113-9. PubMed ID: 17549355
    [Abstract] [Full Text] [Related]

  • 37. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Sep 15; 117(1):45-54. PubMed ID: 18791823
    [Abstract] [Full Text] [Related]

  • 38. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y.
    Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.